A 2018 review in the International Journal of Molecular Sciences compiled transcriptome-profiling data showing thousands of human genes flagged as up- or down-regulated under GHK-Cu exposure across multiple cell-type studies, framing the compound's pleiotropy at the regulatory-network level (PMID 29986520)
REDEFINE 2 (Phase 3a, NEJM 2025) Davies et al., n=1,206, 68 weeks, T2D + BMI 27
The information below, describing the clinical pharmacology of cyanocobalamin, has been derived from studies with injectable vitamin B 12
Complexity High Option Added pathway GHRH, GH, and IGF-1 Direct retatrutide stack trial None identified Main research question Could a more clinically studied GHRH analog affect visceral-fat research
Think of it as a simple "meet and greet" between the product and your skin
GeroScience (2023) 5